Artificial Intelligence Applied to clinical trials: opportunities and challenges

BACKGROUND: Clinical Trials (CTs) remain the foundation of safe and effective drug development. Given the evolving data-driven and personalized medicine approach in healthcare, it is imperative for companies and regulators to utilize tailored Artificial Intelligence (AI) solutions that enable expedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Askin, Scott, Burkhalter, Denis, Calado, Gilda, El Dakrouni, Samar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974218/
https://www.ncbi.nlm.nih.gov/pubmed/36923325
http://dx.doi.org/10.1007/s12553-023-00738-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974218/
https://www.ncbi.nlm.nih.gov/pubmed/36923325
http://dx.doi.org/10.1007/s12553-023-00738-2

Ejemplares similares